Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients

The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3biCffi
via IFTTT